Home

Penumbra, Inc. Common Stock (PEN)

262.28
-10.96 (-4.01%)
NYSE · Last Trade: Apr 4th, 4:42 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Penumbra, Inc. Common Stock (PEN)

AngioDynamics ANGO -7.23%

AngioDynamics, which specializes in innovative, minimally invasive medical devices, directly competes with Penumbra in the vascular market. AngioDynamics focuses on designing products with specific procedural benefits, such as ease of use and patient safety, which can provide them a competitive edge in market segments that prioritize these attributes. However, they are generally smaller and less diversified than Penumbra.

Boston Scientific BSX -8.93%

Boston Scientific competes with Penumbra primarily in the fields of neurovascular devices and interventional cardiology. The company has a strong emphasis on innovation, often bringing a wider range of products to market that cater to various therapeutic areas. Their established brand reputation and large customer base give them a significant advantage in distribution and market penetration over Penumbra.

Medtronic MDT -5.70%

Medtronic is a global leader in medical technology and competes with Penumbra in the neurovascular and peripheral vascular markets. With a broader portfolio and established market presence, Medtronic leverages its extensive research and development capabilities and financial resources to innovate and expand its product lines, which provides a competitive edge over Penumbra, particularly in terms of scale and reach.

Stryker Corporation SYK -6.07%

Stryker Corporation is a significant player in the medical technology field, competing with Penumbra in the development of devices for surgery and neurovascular interventions. Stryker's competitive advantage stems from its diverse product offerings and strong financial backing, enabling extensive marketing and R&D resources, thereby positioning it as a leader in the market compared to Penumbra’s more specialized focus.

Trelleborg AB

Trelleborg focuses on specialized solutions in medical devices, including advanced materials for interventional solutions, competing with Penumbra in niche markets. While Trelleborg may not have the same broad market recognition as larger companies, its expertise in materials and engineering provides a unique competitive advantage in specific applications, allowing for specialized products that cater to certain medical needs.